# Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects

> **NCT00360568** · PHASE3 · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 62 (actual)

## Conditions studied

- Dyskinesias
- Parkinson's Disease
- Severe Motor Fluctuations

## Interventions

- **DRUG:** Levodopa-carbidopa intestinal gel
- **DEVICE:** CADD-Legacy® 1400 ambulatory infusion pump
- **DEVICE:** PEG tube
- **DEVICE:** J-tube

## Key facts

- **NCT ID:** NCT00360568
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2015-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00360568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00360568, "Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00360568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*